ASX Announcements
Westpac Banking Corporation (ASX: WBC) – Westpac Q3 2026 Quarterly Update
Westpac Banking Corporation has reported unaudited net profit of $1.8 billion for the third quarter of 2026, up 3 percent from the 1H26 average and...
Contact Energy (ASX: CEN) – Contact Energy FY26 Full Year Results
Contact Energy has reported a transformational year with net profit of $423 million for FY26, representing a 62% increase from the prior year's $261...
Contact Energy (ASX: CEN) – Contact Energy FY26 Full Year Results
Contact Energy's FY26 results demonstrate a resilient operational turnaround despite softer top-line performance, with net profit climbing 27.8% to...
St Barbara (ASX: SBM) – St Barbara Retraction and Updated Announcement
St Barbara Limited has retracted historical surface sample exploration results from its 5 August announcement on accelerating Nova Scotia activity,...
Metcash (ASX: MTS) – Metcash Files 2025 Annual Report
Metcash Limited has lodged its 2026 Annual Report with the ASX, formally presenting the financial and operational performance of Australia's largest...
Charter Hall Retail REIT (ASX: CQR) – CQR Files 2026 Full Year Results
Charter Hall Retail REIT delivered earnings growth of 4.0 percent in FY26 with operating earnings of 26.4 cents per unit, while providing guidance...
Charter Hall Retail REIT (ASX: CQR) – Charter Hall Retail 2026 Full Year Results
Charter Hall Retail REIT has completed a significant transformation, announcing its transition to a balanced 50/50 portfolio mix between convenience...
Charter Hall Retail REIT (ASX: CQR) – Files 2025 Full Year Accounts
Charter Hall Retail REIT reported a statutory profit of $389.4 million for the year ended 30 June 2026, representing a substantial 78.4% increase...
ResMed Inc (ASX: RMD) – ResMed Declares Dividend Distribution RMD 4
ResMed has declared a quarterly dividend of USD 0.066 per share for holders of Chess Depositary Instruments trading on the ASX. The announcement,...
ResMed Inc (ASX: RMD) – ResMed Reports Q4 2026 Results
ResMed delivered strong results for fiscal year 2026, with full-year revenue reaching $5.7 billion, representing 10% growth or 8% growth on a...